invokana
(canagliflozin)Janssen Pharmaceuticals, Inc.
Usage: INVOKANA (canagliflozin) is indicated as an adjunct to diet and exercise for improving glycemic control in adults and pediatric patients with type 2 diabetes. It reduces risks of major cardiovascular events and end-stage kidney disease in adults with type 2 diabetes and specific health complications. Usage in type 1 diabetes or severe renal impairment is not recommended.